Ausgabe 4/2023
Inhalt (23 Artikel)
Correction to: Effect of Insulin Resistance on Recurrence After Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation
Zhe Wang, Yi-Jia Wang, Zhi-Yu Liu, Qing Li, Ya-Wei Kong, Ying-Wei Chen, Yi-Hong Sun, Jian-Zeng Dong
MicroRNA-145 in Cardiovascular Disease: an Insufficiently Explored and Controversial Research Area
Yingchun Xu, Yuguang Fan, Chunbo Miao
2-Arachidonoylglycerol in Cardiovascular Disease: Angel or Demon?
Jinzhen Cui, Qiuxia Zhang, Yuguang Fan
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes
Tomoyuki Kawada
The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
De-Gang Mo, Mei-Mei Du
Surgical or Percutaneous Coronary Revascularization for Heart Failure: a Focus on Symptoms and Stenosis
Patrick Sulzgruber, Ulrike Baumer, Alexander Niessner
Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury
Yochai Birnbaum, Regina Ye, Huan Chen, Leif Carlsson, Carl Whatling, Ola Fjellström, Erik Ryberg, Yumei Ye
2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway
Zhengjie Chen, Liangyu Zheng, Gang Chen
MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3
Yun Liu, Jing Hu, Weiwei Wang, Qian Wang
Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD)
Shipra Bhansali, Amit Kumar Yadav, Chetan Bakshi, Veena Dhawan
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Daniel Tobias Michaeli, Julia Caroline Michaeli, Tobias Boch, Thomas Michaeli
Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response
Fernando Scudiero, Mario E. Canonico, Giuseppe D. Sanna, Filippo Dossi, Angelo Silverio, Gennaro Galasso, Giovanni Esposito, Italo Porto, Guido Parodi
Effect of Insulin Resistance on Recurrence after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation
Zhe Wang, Yi-Jia Wang, Zhi-Yu Liu, Qing Li, Ya-Wei Kong, Ying-Wei Chen, Yi-Hong Sun, Jian-Zeng Dong
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China
Shuyi Wu, Nianxu Huang, Xia Chen, Shaojun Jiang, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin, Yanxia Zhang, Lang Zou, Yuxin Liu, Min Zhang, Xiumei Liu, Zhu Zhu, Jianjun Sun, Shanshan Hong, Weibin She, Jinhua Zhang
Results from the “Me & My Heart” (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary Syndrome
Florian Krackhardt, Magnus Jörnten-Karlsson, Matthias Waliszewski, Mikael Knutsson, Anna Niklasson, Karl-Friedrich Appel, Ralf Degenhardt, Alexander Ghanem, Till Köhler, Marc-Alexander Ohlow, Carsten Tschöpe, Heinz Theres, Jürgen vom Dahl, Björn W. Karlson, Lars S. Maier
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients
Peter Winkle, Steven Goldsmith, Michael J. Koren, Serge Lepage, Jennifer Hellawell, Ashit Trivedi, Kate Tsirtsonis, Siddique A. Abbasi, Allegra Kaufman, Richard Troughton, Adriaan Voors, Jean-Sebastien Hulot, Erwan Donal, Navid Kazemi, Joel Neutel
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases
Martin H. Strauss, Alistair S. Hall, Krzysztof Narkiewicz
Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic Review
Omar Giacinto, Alessandro Minati, Mario Lusini, Francesco Cardetta, Sara Saltarocchi, Mizar D’Abramo, Fabio Miraldi, Massimo Chello
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis
Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine L. De Backer, Lies Lahousse
Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety
Sumon Roy, Robert A. Kloner, Fadi N. Salloum, Ion S. Jovin
Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials
J. Triska, B. F. Uretsky, B. Pitt, Y. Birnbaum
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
Pedro Vaz-Salvador, Rui Adão, Inês Vasconcelos, Adelino F. Leite-Moreira, Carmen Brás-Silva
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
Marianna Puccini, Christian Rauch, Kai Jakobs, Julian Friebel, Adel Hassanein, Ulf Landmesser, Ursula Rauch